Effects of Lycium barbarum. polysaccharide on type 2 diabetes mellitus rats by regulating biological rhythms

Document Type: Original Article


1 Department of Pharmaceutical Engineering, College of Life Science & Biotechnology, Heilongjiang August First Land Reclamation University, Daqing High-Tech Industrial Development Zone, China

2 Department of Biochemistry and Molecular Biology, Basic Medical Science College, Harbin Medical University, Harbin China

3 School of Basic Medical Sciences, Jiamusi University, No.188 Xuefu Street, Jiamusi City, Heilongjiang Province, China

4 Department of Nephrology, Daqing people’s Hospital, No.213 Jianshe Road, Gaoxin District, Daqing City, Heilongjiang Province, China


Objective(s): Type 2 diabetes mellitus (T2DM) is associated with circadian disruption. Our previous experimental results have showed that dietary Lycium barbarum. polysaccharide (LBP-4a) exhibited hypoglycemic and improving insulin resistance (IR) activities. This study was to explore the mechanisms of LBP-4a for improving hyperglycemia and IR by regulating biological rhythms in T2DM rats.
Materials and Methods:The rats of T2DM were prepared by the high-sucrose-fat diets and injection of streptozotocin (STZ). The levels of insulin, leptin and melatonin were measured by enzyme linked immunosorbent assay (ELISA). The effect of LBP-4a on mRNA expression of melatonin receptors (MT2) in epididymal adipose tissue was evaluated by RT-PCR. The expression of CLOCK and BMAL1 in pancreatic islet cells was detected by Western blotting.
Results: Our data indicated that the 24-hr rhythm of blood glucose appeared to have consistent with normal rats after gavaged administration of LBP-4a for each day of the 4 weeks, and the effects of hypoglycemia and improving hyperinsulinemia in T2DM rats treated at high dose were much better than that at low dose. The mechanisms were related to increasing MT2 level in epididymal adipose tissue and affecting circadian clocks gene expression of CLOCK and BMAL1 in pancreatic islet cells.
Conclusion: LBP-4a administration could treat T2DM rats. These observations provided the background for the further development of LBP-4a as a potential dietary therapeutic agent in the treatment of T2DM.


1. Sohail S, Yu L, Bennett DA, Buchman AS, Lim ASP. Irregular 24-hr activity rhythms and the metabolic syndrome in older adults. Chronobiol Int 2015; 10: 1-12.

2. Nishi T, Saeki K, Obayashi K. The effect of blue-blocking intraocular lenses on circadian biological rhythm: protocol for a randomised controlled trial (CLOCK-IOL colour study). BMJ Open 2015; 5: e007930.

3. Wang K, Sun Y, Lin P,  Song J, Zhao R, Li W, et al. Liraglutide Activates AMPK Signaling and Partially Restores Normal Circadian Rhythm and Insulin Secretion in Pancreatic Islets in Diabetic Mice. Biol Pharm Bull 2015; 38: 1142-9.

4. Sohail S, Yu L, Bennett DA, Buchman AS, Lim AS. Diurnal variations of blood glucose by continuous blood glucose monitoring in peritoneal dialysis patients with diabetes. Adv Perit Dial 2014; 30: 54-59.

5. Rakshit K, Thomas AP, Matveyenko AV. Does disruption of circadian rhythms contribute to beta-cell failure in type 2 diabetes? Curr Diab Rep 2015; 14: 474-478.

6. Gale JE, Cox HI, Qian J, Block GD, Colwell CS, Matveyenko AV. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms 2011; 26: 423-433.

7. Peschke E, Bähr I, Mühlbauer E. Experimental and clinical aspects of melatonin and clock genes in diabetes. J Pineal Res 2015; 59: 1-23.

8. Karamitri A, Vincens M, Chen M, Jockers R. Involvement of melatonin MT2 receptor mutants in type 2 diabetes development. Med Sci (Paris) 2013; 29: 778-784.

9. Ríos-Lugo MJ, Jiménez-Ortega V, Cano-Barquilla P, Mateos PF, Spinedi EJ, Cardinali DP, et al. Melatonin counteracts changes in hypothalamic gene expression of signals regulating feeding behavior in high-fat fed rats. Horm Mol Biol Clin Investig 2015; 21: 175-183.

10. Hu YT, Li Q, Yang H. Protective effect of polysaccharides on simulated microgravity-induced functional inhibition of human NK cells. Carbohydr Polym 2014; 101: 819-827.

11. Zhao R, Li QW, Li J, Zhang Tao. Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 2009; 87: 711-719.

12. Zhao R, Qiu B, Li QW. LBP-4a improves insulin resistance via translocation and activation of GLUT4 in OLETF rats. Food Funct 2014; 5: 811-820.

13. Wu M, Ji H, Li P. Study of hypoglycemic mechanism of Tang kening on diabetic rats induced by STZ. Journal of Nanjing Chinese Trational Medical and Medicine University 1999; 15: 22-25.

14. Szot GL, Koudria P, Bluestone JA. Murine pancreatic islet isolation. J Vis Exp 2007; 7: 255-256.

 15. Fred Z, Jean AK, David EB. Inhibition of Isoproterenol-  Induced Lipolysis in Rat Inguinal Adipocytesin Vitroby Physiological Melatonin via a Receptor-Mediated Mechanism. Endocrinology 2014; 142: 3783-3790.

16. Nelson W, Tong YL. Lee JK, Halberg F. Methods for cosinorrhythmometry. Chronobiologia 1979; 6: 305-323.

17. Šoltésová D, Monošíková J, Koyšová L, Veselá A, Mravec B, Herichová I. Effect of Streptozotocin-induced Diabetes on Clock Gene Expression in Tissues Inside and Outside the Blood-brain Barrier in Rat. Exp Clin Endocrinol Diabetes 2013; 121: 466-474.

18. Wautem M, Considine RV, Yudkin JS. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res 2003; 35: 92-96.

19. Cuesta M. From daily behavior to hormonal and neurotransmitters rhythms: comparison between diurnal and nocturnal rat species. Horm Behav 2009; 55: 338-347.

20 Koyanagi S. Molecular basis of choronopharmacology. Seikagaku 2014; 86: 774-777.

21. Sancar A, Lindsey-Boltz LA, Gaddameedhi S, Selby CP, Ye R, Chiou YY, et al. Circadian clock, cancer, and chemotherapy. Biochemistry 2015; 54: 10-23.

22. Markova-Car EP, Jurišić D, Ilić N, Pavelić SK. Running for time: circadian rhythms and melanoma.Tumour Biol 2014; 35: 8359-68.

23. Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, Mizuguchi K, et al. Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010; 59: 2495-504.

24. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.

25. Myers, JMG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010; 21: 643-51.

26. Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-36.

27. Manrique C, Sowers JR. Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators. Cardiorenal Med 2014; 4: 244-256.

28. Mulder H, Nagorny CL, Lyssenko V. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia 2009; 52: 1240-1249.

29. Geoffroy PA, Lajnef M, Bellivier F, Jamain S, Gard S, Kahn JP, et al. Genetic association study of circadian genes with seasonal pattern in bipolar disorders. Sci Rep 2015; 19: 10232.

30. Buxton OM, Cain SW, O’Connor SP. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med 2012; 4: 129-143.

31. Gekakis N., Staknis D, Nguyen HB. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998; 280: 1564-1569.

32. Marcheva B, Ramsey KM, Buhr ED. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010; 466: 627-631.